Release Date: October 2005 Expiration Date: October 2007
Supported by an educational grant from Roche Laboratories Inc.
FACULTY
FINANCIAL DISCLOSURE
Arnold S. Monto has served as a consultant for Chiron Corporation, GlaxoSmithKline, MedImmune Inc., Roche Laboratories, Inc., and Solvay Pharmaceuticals, Inc and has received grant/research support from Sanofi Pasteur.
ACCREDITATION STATEMENTS
Pharmacists Jobson is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program No.: 430-000-05-108-H01 Credits: 2.0 hours (.20 ceu)
Physician Continuing Medical Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Jobson Publishing, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Nursing Continuing Education CNA/ANCC This educational activity for 1.9 contact hours is provided by Postgraduate Institute for Medicine (PIM). PIM is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
California Board of Registered Nursing Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.9 contact hours.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of pharmacists, physicians, physician assistants, nurse practitioners and registered nurses.
GOAL
To instruct healthcare professionals with a variety of biomedical backgrounds in the basic virology, clinical and public health characteristics of influenza to enhance its prevention and treatment.
EDUCATIONAL OBJECTIVES
At the conclusion of this program, participants will be able to: 1. Discuss the differences between pandemic and interpandemic influenza in terms of occurrence and viruses involved; 2. Describe strategies for prevention and treatment of pandemic and interpandemic influenza; 3. Review the differences between the roles of vaccine and antivirals in prevention and control of influenza; 4. Discuss the science which underlies recommendations for vaccine and antiviral use; 5. Describe the different types of vaccines and antivirals available, including their strengths and weaknesses; and 6. Explain the differences between special situations such as nursing homes and other closed and open populations in terms of control and treatment.
1. Discuss the differences between pandemic and interpandemic influenza in terms of occurrence and viruses involved; 2. Describe strategies for prevention and treatment of pandemic and interpandemic influenza; 3. Review the differences between the roles of vaccine and antivirals in prevention and control of influenza; 4. Discuss the science which underlies recommendations for vaccine and antiviral use; 5. Describe the different types of vaccines and antivirals available, including their strengths and weaknesses; and 6. Explain the differences between special situations such as nursing homes and other closed and open populations in terms of control and treatment.
Disclosure of Unlabeled Use and Disclaimer The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Power-Pak C.E., PIM and Roche Laboratories Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer’s package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the Food and Drug Administration. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.